Generated by DeepSeek V3.2| messenger RNA | |
|---|---|
| Name | Messenger RNA |
| Type | Nucleic acid |
| Function | Template for protein synthesis |
| Components | Ribonucleotides |
| Location | Cytoplasm, Nucleus |
messenger RNA is a single-stranded RNA molecule that carries the genetic code from DNA in the cell nucleus to the ribosome in the cytoplasm, where it serves as a template for protein synthesis. This process, known as translation, is a fundamental step in gene expression and is essential for all known forms of life. The discovery of this molecule provided a critical link between the genetic information stored in DNA and the functional proteins that carry out cellular processes.
The molecule is typically composed of a linear chain of ribonucleotides, each containing one of four nitrogenous bases: adenine, uracil, cytosine, or guanine. Its primary structure includes several key regions: the 5' cap, the 5' untranslated region, the coding sequence, the 3' untranslated region, and the poly(A) tail. These structural elements are crucial for stability, nuclear export, and efficient translation initiation. The sequence of the coding region is complementary to the template strand of a gene and is directly read by the ribosome in sets of three nucleotides called codons, each specifying a particular amino acid.
Synthesis begins with the process of transcription, catalyzed by the enzyme RNA polymerase II in eukaryotic cells. This enzyme binds to a promoter region on the DNA and synthesizes a precursor molecule known as pre-mRNA. In eukaryotes, this precursor undergoes extensive post-transcriptional modification within the nucleus, including the addition of the 5' cap and poly(A) tail, and the removal of non-coding intron sequences through RNA splicing carried out by the spliceosome. In contrast, prokaryotic molecules are generally synthesized and used for translation without these modifications, as they lack a separate cell nucleus.
The mature molecule is transported from the nucleus to the cytoplasm through nuclear pores, where it engages with ribosomes. The ribosome assembles around the molecule, and transfer RNA molecules, each carrying a specific amino acid, recognize the codons via their complementary anticodon sequences. This process, translation, is facilitated by various translation factors and requires energy from guanosine triphosphate. The genetic code is nearly universal, with specific codons like AUG signaling the start of translation and others like UAA acting as stop signals.
The molecule has become a cornerstone of modern biotechnology and therapeutic development. A landmark application is in COVID-19 vaccines, such as those developed by Pfizer and Moderna, which use lipid nanoparticle-encapsulated molecules to instruct cells to produce the SARS-CoV-2 spike protein, eliciting an immune response. This platform is being investigated for vaccines against other pathogens like influenza and HIV. In research, techniques like RNA interference and CRISPR screening often utilize synthetic molecules or target endogenous ones to study gene function. Furthermore, mRNA-based therapeutics are being explored for cancer immunotherapy and protein replacement therapies for diseases like cystic fibrosis.
The concept of an intermediate molecule carrying information from DNA to ribosomes was first suggested by Jacques Monod and François Jacob. The molecule itself was identified and named in 1961 through a series of elegant experiments by Sydney Brenner, François Jacob, and Matthew Meselson at the California Institute of Technology, and independently by James Watson's group. Their work, building on earlier discoveries by Marshall Nirenberg and Heinrich Matthaei who deciphered the genetic code, confirmed its role as the informational template. Subsequent research by Phillip Sharp and Richard Roberts on RNA splicing in adenovirus revealed the split-gene structure of eukaryotic genes, a finding recognized by the Nobel Prize in Physiology or Medicine.